—
C+
C+ The full Closelook — membership. Open the C+ overview

Laboratorios Farmaceuticos ROVI (ROVI.MC) — Technical state

As of 2026-09-17 — re-computed nightly across the coverage universe. Closelook diary readings, not advice.

Recovery attempt under the 200-day

Trades +0.9% vs the 50-day and -11.2% vs the 200-day average, 31.2% below the 52-week high and +10.9% off the 52-week low; a death cross printed 64 sessions ago. Computed from daily closes.

The moving-average stack

Continue: the ROVI.MC chart & overview · the signal board

FAQ · from the current data · as of 2026-09-17

Quick answers

What is the current Closelook signal on ROVI.MC?

Recovery attempt under the 200-day — Trades +0.9% vs the 50-day and -11.2% vs the 200-day average, 31.2% below the 52-week high and +10.9% off the 52-week low; a death cross printed 64 sessions ago. Computed from daily closes. As of 2026-09-17; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is ROVI.MC above its 50-day and 200-day moving averages?

As of 2026-09-17, Laboratorios Farmaceuticos ROVI trades +0.9% above its 50-day and -11.2% below its 200-day average, with the 20-day -1% away.

How far is ROVI.MC from its 52-week high?

31.2% below the 52-week high and 10.9% above the 52-week low, as of 2026-09-17.

Related in the Closelook universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.